Doptelet® SMS Terms of Service | DOPTELET® (avatrombopag)

Discover the Doptelet Copay
Assistance Program

Eligible commercially insured patients may qualify for the Doptelet Copay Assistance Program

What's the program?

Eligible patients may pay as little as $0 for each Doptelet prescription
Annual maximum benefit up to $15,000

Eligible patients must:

Have commercial insurance that covers Doptelet
Not be enrolled in any state or federal healthcare program such as Medicare, Medicaid, Medigap, Veterans Affairs (VA), Department of Defense (DOD), or TRICARE
Be ≥1 years of age or older
Be a resident in the United States or a US Territory

How to enroll:

Approved pharmacies, healthcare professionals, and Doptelet Connect can enroll patients
Patients can enroll themselves as well as their caregivers
Please call 1-833-368-2663 Monday–Friday 8am–7pm ET for more information

Terms and Conditions

Patients pay as little as $0 per prescription. Copay Assistance Program has an annual calendar cap of $15,000
The Copay Assistance Program is void where prohibited by law, taxes, or restricted
This offer is non-transferable, no substitutions are permissible, and this offer cannot be combined with any other rebate/coupon, free trial, or similar offer for the specified prescription
Sobi, Inc. reserves the right to rescind, revoke, or amend this offer at any time without notice
The Copay Assistance Program for Doptelet is not insurance and is not intended to substitute for insurance
Patients, pharmacists, and healthcare providers must not seek reimbursement from health insurance or any third party for any part of the benefit received by the patient through this Copay Assistance Program. Patients must not seek reimbursement from any health savings, flexible spending, or other healthcare reimbursement accounts for the amount of assistance received from the Copay Assistance Program
Certain information pertaining to your use of the Copay Assistance Program will be shared with Sobi, Inc., the sponsor of the Copay Assistance Program. The information disclosed will include the date the prescription is filled, the number of pills or product dispensed by the pharmacists, and the amount of your copay that will be paid for by using this Copay Assistance Program. For more information, please see the Sobi Privacy Policy at https://sobi-northamerica.com/privacy-policy
Acceptance in this Copay Assistance Program is not conditioned on any past, present, or future purchase, including additional doses
Enrollment for the Copay Assistance Program is valid through the calendar year
Sobi reserves the right to change program terms at any time

Terms of Service

When you opt in to the service, we will send a message to confirm your signup. You will receive no more than 1 message/week. Message and data rates may apply.

You can cancel this service at any time by texting "STOP" to 62314. We will send a reply message to confirm that you have been unsubscribed. After this, you will no longer receive messages from us.

If you forget what keywords are supported, text "HELP" to 62314. We will respond with instructions on how to use our service as well as how to unsubscribe.

Participating Tier 1 Carriers: AT&T, Sprint/Boost/Virgin, T-Mobile, MetroPCS, Verizon Wireless. T-Mobile is not liable for delayed or undelivered messages.

If you have any questions about your text plan or data plan, it is best to contact your wireless provider.

For all questions about the services provided by this short code, you can send an email info@sobi.com, call 800-555-5555 or visit https://sobi-northamerica.com/contact-us.

If you have any questions regarding privacy, please read our Privacy Policy at https://sobi-northamerica.com/privacy-policy.

Indication & Important Safety Information

What are DOPTELET (avatrombopag) and DOPTELET Sprinkle (avatrombopag)?

DOPTELET is a prescription medicine used to treat low blood platelet counts in:

Adults with long-lasting (chronic) liver disease (CLD) who are scheduled to have a medical or dental procedure
Adults with chronic immune thrombocytopenia (ITP) when other treatments have not worked well enough.
Children 1 year and older with persistent or chronic ITP when other treatments have not worked well enough

DOPTELET tablets and DOPTELET Sprinkle are different dosage forms of DOPTELET.

DOPTELET and DOPTELET Sprinkle are not used to make platelet counts normal.

It is not known if DOPTELET or DOPTELET Sprinkle are safe and effective in children younger than 1 year of age.

IMPORTANT SAFETY INFORMATION

Before you take DOPTELET or DOPTELET Sprinkle, tell your doctor about all your medical conditions, including if you:

Have ever had a blood clot
Are pregnant or plan to become pregnant. DOPTELET or DOPTELET Sprinkle may harm your unborn baby. Tell your healthcare provider if you become pregnant or think you may be pregnant during treatment with DOPTELET or DOPTELET Sprinkle
Are breastfeeding or plan to breastfeed. It is not known if DOPTELET or DOPTELET Sprinkle passes into your breast milk. Do not breastfeed during your treatment with DOPTELET and DOPTELET Sprinkle for at least 2 weeks after the last dose. Talk to your healthcare provider about the best way to feed your baby during this time

Tell your healthcare provider about all of the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. DOPTELET or DOPTELET Sprinkle may affect the way other medicines work, and other medicines may affect the way DOPTELET or DOPTELET Sprinkle works.

What are the side effects of DOPTELET or DOPTELET Sprinkle?

DOPTELET or DOPTELET Sprinkle may cause serious side effects including blood clots. People with CLD or persistent or chronic ITP and people with certain blood clotting conditions may have an increased risk of developing blood clots. Tell your healthcare provider right away if you get signs and symptoms of a blood clot, including:

Swelling, pain, or tenderness in your legs
Shortness of breath
Chest pain

Fast heartbeat
Stomach (abdominal) pain or tenderness

The most common side effects of DOPTELET in adults with CLD are fever, stomach (abdominal) pain, nausea, headache, tiredness, and swelling of hands and feet.

The most common side effects of DOPTELET in adults with chronic ITP are headache, tiredness, bruising, nosebleed, upper respiratory infection, joint pain, bleeding gums, purple or red spots on your skin, and runny nose.

The most common side effects of DOPTELET or DOPTELET Sprinkle in children with persistent or chronic ITP are viral infection, runny nose, cough, fever, and pain in the mouth or throat.

These are not all of the possible side effects of DOPTELET or DOPTELET Sprinkle. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Please see the DOPTELET and DOPTELET Sprinkle full Prescribing Information.

Indication & Important Safety Information

What are DOPTELET (avatrombopag) and DOPTELET Sprinkle (avatrombopag)?

DOPTELET is a prescription medicine used to treat low blood platelet counts in:

Adults with long-lasting (chronic) liver disease (CLD) who are scheduled to have a medical or dental procedure
Adults with chronic immune thrombocytopenia (ITP) when other treatments have not worked well enough.
Children 1 year and older with persistent or chronic ITP when other treatments have not worked well enough

What are DOPTELET (avatrombopag) and DOPTELET Sprinkle (avatrombopag)?

DOPTELET is a prescription medicine used to treat low blood platelet counts in:

Adults with long-lasting (chronic) liver disease (CLD) who are scheduled to have a medical or dental procedure
Adults with chronic immune thrombocytopenia (ITP) when other treatments have not worked well enough.
Children 1 year and older with persistent or chronic ITP when other treatments have not worked well enough

DOPTELET tablets and DOPTELET Sprinkle are different dosage forms of DOPTELET.

DOPTELET and DOPTELET Sprinkle are not used to make platelet counts normal.

It is not known if DOPTELET or DOPTELET Sprinkle are safe and effective in children younger than 1 year of age.

IMPORTANT SAFETY INFORMATION

Before you take DOPTELET or DOPTELET Sprinkle, tell your doctor about all your medical conditions, including if you:

Have ever had a blood clot
Are pregnant or plan to become pregnant. DOPTELET or DOPTELET Sprinkle may harm your unborn baby. Tell your healthcare provider if you become pregnant or think you may be pregnant during treatment with DOPTELET or DOPTELET Sprinkle
Are breastfeeding or plan to breastfeed. It is not known if DOPTELET or DOPTELET Sprinkle passes into your breast milk. Do not breastfeed during your treatment with DOPTELET and DOPTELET Sprinkle for at least 2 weeks after the last dose. Talk to your healthcare provider about the best way to feed your baby during this time

What are the side effects of DOPTELET or DOPTELET Sprinkle?

Swelling, pain, or tenderness in your legs
Shortness of breath
Chest pain

Fast heartbeat
Stomach (abdominal) pain or tenderness

The most common side effects of DOPTELET in adults with CLD are fever, stomach (abdominal) pain, nausea, headache, tiredness, and swelling of hands and feet.

The most common side effects of DOPTELET or DOPTELET Sprinkle in children with persistent or chronic ITP are viral infection, runny nose, cough, fever, and pain in the mouth or throat.

These are not all of the possible side effects of DOPTELET or DOPTELET Sprinkle. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Please see the DOPTELET and DOPTELET Sprinkle full Prescribing Information.